IMPACT OF CHRONIC THROMBOCYTOPENIA ON CLINICAL OUTCOMES AFTER TRANSCATHETER VALVULAR INTERVENTIONS AND CARDIAC DEVICES IMPLANTATIONS (PROPENSITY MATCHED ANALYSIS OF THE NATIONAL INPATIENT SAMPLE)

The impact of chronic thrombocytopenia (cTCP), defined as platelets count of < 150,000 cells/ml, on clinical outcomes after transcatheter aortic valve implantation (TAVI), MitraClip, permenant pacemaker(PPM), implantable-cardioverter defibrillator(ICD), cardiac resynchronization therapy(CRT), left